Ocular Therapeutix, Inc. (OCUL) saw a 25% increase in shares on Thursday following the announcement of a securities purchase agreement with institutional accredited investors.
OCUL is trading on the Nasdaq at $9.43, up 25.46% or $1.91 per share. It has traded between $2.00 and $9.75 in the past 52-week period.
The agreement involves the sale of securities in a private placement, generating around $325 million in gross proceeds.
The company will sell 32,413,560 shares of common stock at $7.52 per share and issue pre-funded warrants for the purchase of up to 10,805,957 shares at $7.519 per warrant. Each warrant has an exercise price of $0.001 per share, can be exercised immediately, and remains valid until fully exercised.
The private placement is set to close on February 26, 2024, pending standard closing conditions.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.